English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Replimune's melanoma drug rejected again as FDA faces scrutiny over regulatory consistency
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Merck and others to present key cancer research data at AACR 2026 meeting
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Study finds smoothies linked to better health than juices or low fruit intake
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Study finds Finnish sauna sessions rapidly increase immune cells in adults
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Researchers link NHS Talking Therapies access to reduced joblessness in mental health patients
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Experts outline guidance on rice-based formula for infants with cow’s milk allergy
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Study links ultra-processed food intake to increased muscle fat in adults at risk for knee osteoarthritis
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Study finds exosomal miR-122-3p may serve as biomarker for MASLD

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes